SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14,371,028 | +1.3% | 14,627,000 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $14,188,000 | -0.1% | 14,627,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $14,197,000 | -1.0% | 14,627,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $14,344,000 | -0.5% | 14,627,000 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $14,417,000 | +0.3% | 14,627,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $14,371,000 | -0.1% | 14,627,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,380,000 | +2.0% | 14,627,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $14,101,000 | +1.7% | 14,627,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $13,871,000 | +3.0% | 14,627,000 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $13,473,000 | +4.7% | 14,627,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $12,873,000 | +9.6% | 14,627,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $11,745,000 | -11.3% | 14,627,000 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $13,240,000 | -2.3% | 14,627,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $13,546,000 | +44.2% | 14,627,000 | +51.9% | 0.00% | +100.0% |
| Q2 2019 | $9,395,000 | – | 9,627,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|